RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from two pivotal Phase 3 trials of the investigational, ...

Serology is indicated when documentation of HIV status is inadequate. Much has changed since the first case of AIDS was identified. Updated guidelines discuss transmission, diagnosis, risk screening, ...

People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their body. But some people, known as 'post-treatment controllers,' have been able to ...

You may have heard about Descovy (des-ko'-vee), a medicine approved by the FDA in 2015. Descovy is approved to treat HIV. It can also help prevent people from getting HIV through sex. People with HIV ...

Giving adolescents living with HIV high-dose Vitamin D and calcium supplements can help improve their bone density and reduce the risk of fractures, a new study suggests. Sexual violence against ...

Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...

You may have heard about Symtuza, a medicine approved by the FDA in 2018 to treat people with HIV who have not been treated yet. It may also be used to replace another medicine for treating HIV in ...

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

TB remains the leading cause of death among people living with HIV. Uganda is a high TB-burden country, and HIV accelerates ...